Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection
Clinical trial NCT03817268 · UNKNOWN
Trial details
- NCT number
- NCT03817268
- Sponsor
- The First Affiliated Hospital of Anhui Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-16
- Primary completion
- 2026-01-16
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.